10-fold CROSS VALIDATION Experiment on ontology:


Fold #0 **************************************************************************************************
DecreasedRiskBrCa0.01
DecreasedRiskBrCa0.6
PersistentSideEffectsInst
ProtoERNegLNNegStage2BrCa
ProtoLNNeg
IncreasedBrCaDFS1.5
ProtoClonidine
IncreasedRiskGastricCa3.0
IncreasedOS1.2
ProtoEndoAbnormality
RiskRetinopathy0.12
ProtoEndoCa
DecreasedRiskFatalMI0.37
IncreasedLumbarBMD1.008
ProtoERPosLNNegStage1BrCa
IncreasedRiskPersistentSideEffects2.3
IncreasedRiskEndometrialCancer7.5
RadialBMDLevel
DecreasedPlasmaPlateletCount0.92
ProtoPoorPrognosis
ProtoPostmenopausal
ProtoStage1
TamC40mg
ProtoPFTChemoTam
LumbarBMDLevel
DecreasedRiskHotFlushes0.8
IncreasedBrCaDFSREF
DecreasedRiskCardiacDisease0.68
IncreasedBrCaDFS1.2
ProtoERPos
ProtoRetinopathy
DecreasedLumbarBMD0.993
IncreasedBrCaDFS1.3
IncreasedRiskCRC1.9
IncreasedBrCaDFS1.1
TamA20mg
ProtoMFTChemoTam
IncreasedRiskEndometrialCancer4.1
ProtoStage2
ProtoEarlyCMFTChemoTam
ProtoEndometrialAbnormality
DecreasedLDL0.88
IncreasedRiskSideEffects23
PlasmaFibrinogen
PlasmaLDL
ProtoStage4
ProtoStage3
ProtoERPosLNPosStage2BrCa
IncreasedRiskRetinopathy1.52
NoChangeRiskEndometrialAbnormality1
TamD2Yr
ProtoERNegLNPosStage2BrCa
RiskOvarianCyst0.11
ProtoNoChangeOS
IncreasedLumbarBMD1.012
IncreasedOS1.03
DecreasedBrCaDFS0.5
ProtoPremenopausal
DecreasedRiskBrCa0.55
MsJones
ProtoERNeg
RiskOvarianCyst0.06
ProtoACT
DecreasedRadialBMD_NOS
IncreasedCardiacDSS1.52
IncreasedRiskGastricCa3.2
ProtoGastricCa
ProtoColorectalCa
ProtoStroke
PlasmaPlatelet
ECMFTypeInstance
ProtoVenousThrombosis
IncreasedRiskEndometrialCancer6.4
ProtoPAFTChemoTam
DecreasedLumbarBMD0.986
IncreasedBrCaDFS1.x
IncreasedOS1.1
RiskEndometrialCa0.005
NoChangeRadialBMD1.0
NoChangeBrCaDFS1
DecreasedPlasmaFibrinogenLevel0.85
ProtoLNPos
ProtoNonFatalMI
ProtoERPosLNPosStage1BrCa
IncreasedLumbarBMD1.006
Tam30mg
RiskEndometrialAbnormality3.9
TamFgt5Yr
ProtoFatalMI
IncreasedRiskEndometrialCancer2.3
ProtoHotFlushes
ProtoPRNeg
ProtoLateCMFTChemTam
ProtoPRPos
DecreasedEndoCaDFS0.66
ProtoERNegLNNegStage1BrCa
IncreasedRiskEndometrialCancer6.0
TamE5Yr
IncreasedRiskCataracts1.14
IncreasedOS1.02
IncreasedBrCaDFS1.21


Fold #1 **************************************************************************************************
Thing
IncreasedBrCaDFS1.05
IncreasedBrCaDFS1.7
DecreasedBrCaDFS0.8
IncreasedRiskEndometrialCancer2.53
ProtoERNegLNPosStage1BrCa
DecreasedEndoCaDSS0.66
PlasmaCholesterolInst
DecreasedCholesterol0.88
RiskCataracts0.14
ProtoERPosLNNegStage2BrCa
IncreasedRiskVenousThrombosis3.4
DecreasedRiskFatalMI0.37
IncreasedLumbarBMD1.008
ProtoERPosLNNegStage1BrCa
IncreasedRiskPersistentSideEffects2.3
IncreasedRiskEndometrialCancer7.5
RadialBMDLevel
DecreasedPlasmaPlateletCount0.92
ProtoPoorPrognosis
ProtoPostmenopausal
ProtoStage1
TamC40mg
ProtoPFTChemoTam
LumbarBMDLevel
DecreasedRiskHotFlushes0.8
IncreasedBrCaDFSREF
DecreasedRiskCardiacDisease0.68
IncreasedBrCaDFS1.2
ProtoERPos
ProtoRetinopathy
DecreasedLumbarBMD0.993
IncreasedBrCaDFS1.3
IncreasedRiskCRC1.9
IncreasedBrCaDFS1.1
TamA20mg
ProtoMFTChemoTam
IncreasedRiskEndometrialCancer4.1
ProtoStage2
ProtoEarlyCMFTChemoTam
ProtoEndometrialAbnormality
DecreasedLDL0.88
IncreasedRiskSideEffects23
PlasmaFibrinogen
PlasmaLDL
ProtoStage4
ProtoStage3
ProtoERPosLNPosStage2BrCa
IncreasedRiskRetinopathy1.52
NoChangeRiskEndometrialAbnormality1
TamD2Yr
ProtoERNegLNPosStage2BrCa
RiskOvarianCyst0.11
ProtoNoChangeOS
IncreasedLumbarBMD1.012
IncreasedOS1.03
DecreasedBrCaDFS0.5
ProtoPremenopausal
DecreasedRiskBrCa0.55
MsJones
ProtoERNeg
RiskOvarianCyst0.06
ProtoACT
DecreasedRadialBMD_NOS
IncreasedCardiacDSS1.52
IncreasedRiskGastricCa3.2
ProtoGastricCa
ProtoColorectalCa
ProtoStroke
PlasmaPlatelet
ECMFTypeInstance
ProtoVenousThrombosis
IncreasedRiskEndometrialCancer6.4
ProtoPAFTChemoTam
DecreasedLumbarBMD0.986
IncreasedBrCaDFS1.x
IncreasedOS1.1
RiskEndometrialCa0.005
NoChangeRadialBMD1.0
NoChangeBrCaDFS1
DecreasedPlasmaFibrinogenLevel0.85
ProtoLNPos
ProtoNonFatalMI
ProtoERPosLNPosStage1BrCa
IncreasedLumbarBMD1.006
Tam30mg
RiskEndometrialAbnormality3.9
TamFgt5Yr
ProtoFatalMI
IncreasedRiskEndometrialCancer2.3
ProtoHotFlushes
ProtoPRNeg
ProtoLateCMFTChemTam
ProtoPRPos
DecreasedEndoCaDFS0.66
ProtoERNegLNNegStage1BrCa
IncreasedRiskEndometrialCancer6.0
TamE5Yr
IncreasedRiskCataracts1.14
IncreasedOS1.02
IncreasedBrCaDFS1.21


Fold #2 **************************************************************************************************
Thing
IncreasedBrCaDFS1.05
IncreasedBrCaDFS1.7
DecreasedBrCaDFS0.8
IncreasedRiskEndometrialCancer2.53
ProtoERNegLNPosStage1BrCa
DecreasedEndoCaDSS0.66
PlasmaCholesterolInst
DecreasedCholesterol0.88
RiskCataracts0.14
ProtoERPosLNNegStage2BrCa
IncreasedRiskVenousThrombosis3.4
DecreasedRiskBrCa0.01
DecreasedRiskBrCa0.6
PersistentSideEffectsInst
ProtoERNegLNNegStage2BrCa
ProtoLNNeg
IncreasedBrCaDFS1.5
ProtoClonidine
IncreasedRiskGastricCa3.0
IncreasedOS1.2
ProtoEndoAbnormality
RiskRetinopathy0.12
ProtoEndoCa
LumbarBMDLevel
DecreasedRiskHotFlushes0.8
IncreasedBrCaDFSREF
DecreasedRiskCardiacDisease0.68
IncreasedBrCaDFS1.2
ProtoERPos
ProtoRetinopathy
DecreasedLumbarBMD0.993
IncreasedBrCaDFS1.3
IncreasedRiskCRC1.9
IncreasedBrCaDFS1.1
TamA20mg
ProtoMFTChemoTam
IncreasedRiskEndometrialCancer4.1
ProtoStage2
ProtoEarlyCMFTChemoTam
ProtoEndometrialAbnormality
DecreasedLDL0.88
IncreasedRiskSideEffects23
PlasmaFibrinogen
PlasmaLDL
ProtoStage4
ProtoStage3
ProtoERPosLNPosStage2BrCa
IncreasedRiskRetinopathy1.52
NoChangeRiskEndometrialAbnormality1
TamD2Yr
ProtoERNegLNPosStage2BrCa
RiskOvarianCyst0.11
ProtoNoChangeOS
IncreasedLumbarBMD1.012
IncreasedOS1.03
DecreasedBrCaDFS0.5
ProtoPremenopausal
DecreasedRiskBrCa0.55
MsJones
ProtoERNeg
RiskOvarianCyst0.06
ProtoACT
DecreasedRadialBMD_NOS
IncreasedCardiacDSS1.52
IncreasedRiskGastricCa3.2
ProtoGastricCa
ProtoColorectalCa
ProtoStroke
PlasmaPlatelet
ECMFTypeInstance
ProtoVenousThrombosis
IncreasedRiskEndometrialCancer6.4
ProtoPAFTChemoTam
DecreasedLumbarBMD0.986
IncreasedBrCaDFS1.x
IncreasedOS1.1
RiskEndometrialCa0.005
NoChangeRadialBMD1.0
NoChangeBrCaDFS1
DecreasedPlasmaFibrinogenLevel0.85
ProtoLNPos
ProtoNonFatalMI
ProtoERPosLNPosStage1BrCa
IncreasedLumbarBMD1.006
Tam30mg
RiskEndometrialAbnormality3.9
TamFgt5Yr
ProtoFatalMI
IncreasedRiskEndometrialCancer2.3
ProtoHotFlushes
ProtoPRNeg
ProtoLateCMFTChemTam
ProtoPRPos
DecreasedEndoCaDFS0.66
ProtoERNegLNNegStage1BrCa
IncreasedRiskEndometrialCancer6.0
TamE5Yr
IncreasedRiskCataracts1.14
IncreasedOS1.02
IncreasedBrCaDFS1.21


Fold #3 **************************************************************************************************
Thing
IncreasedBrCaDFS1.05
IncreasedBrCaDFS1.7
DecreasedBrCaDFS0.8
IncreasedRiskEndometrialCancer2.53
ProtoERNegLNPosStage1BrCa
DecreasedEndoCaDSS0.66
PlasmaCholesterolInst
DecreasedCholesterol0.88
RiskCataracts0.14
ProtoERPosLNNegStage2BrCa
IncreasedRiskVenousThrombosis3.4
DecreasedRiskBrCa0.01
DecreasedRiskBrCa0.6
PersistentSideEffectsInst
ProtoERNegLNNegStage2BrCa
ProtoLNNeg
IncreasedBrCaDFS1.5
ProtoClonidine
IncreasedRiskGastricCa3.0
IncreasedOS1.2
ProtoEndoAbnormality
RiskRetinopathy0.12
ProtoEndoCa
DecreasedRiskFatalMI0.37
IncreasedLumbarBMD1.008
ProtoERPosLNNegStage1BrCa
IncreasedRiskPersistentSideEffects2.3
IncreasedRiskEndometrialCancer7.5
RadialBMDLevel
DecreasedPlasmaPlateletCount0.92
ProtoPoorPrognosis
ProtoPostmenopausal
ProtoStage1
TamC40mg
ProtoPFTChemoTam
ProtoMFTChemoTam
IncreasedRiskEndometrialCancer4.1
ProtoStage2
ProtoEarlyCMFTChemoTam
ProtoEndometrialAbnormality
DecreasedLDL0.88
IncreasedRiskSideEffects23
PlasmaFibrinogen
PlasmaLDL
ProtoStage4
ProtoStage3
ProtoERPosLNPosStage2BrCa
IncreasedRiskRetinopathy1.52
NoChangeRiskEndometrialAbnormality1
TamD2Yr
ProtoERNegLNPosStage2BrCa
RiskOvarianCyst0.11
ProtoNoChangeOS
IncreasedLumbarBMD1.012
IncreasedOS1.03
DecreasedBrCaDFS0.5
ProtoPremenopausal
DecreasedRiskBrCa0.55
MsJones
ProtoERNeg
RiskOvarianCyst0.06
ProtoACT
DecreasedRadialBMD_NOS
IncreasedCardiacDSS1.52
IncreasedRiskGastricCa3.2
ProtoGastricCa
ProtoColorectalCa
ProtoStroke
PlasmaPlatelet
ECMFTypeInstance
ProtoVenousThrombosis
IncreasedRiskEndometrialCancer6.4
ProtoPAFTChemoTam
DecreasedLumbarBMD0.986
IncreasedBrCaDFS1.x
IncreasedOS1.1
RiskEndometrialCa0.005
NoChangeRadialBMD1.0
NoChangeBrCaDFS1
DecreasedPlasmaFibrinogenLevel0.85
ProtoLNPos
ProtoNonFatalMI
ProtoERPosLNPosStage1BrCa
IncreasedLumbarBMD1.006
Tam30mg
RiskEndometrialAbnormality3.9
TamFgt5Yr
ProtoFatalMI
IncreasedRiskEndometrialCancer2.3
ProtoHotFlushes
ProtoPRNeg
ProtoLateCMFTChemTam
ProtoPRPos
DecreasedEndoCaDFS0.66
ProtoERNegLNNegStage1BrCa
IncreasedRiskEndometrialCancer6.0
TamE5Yr
IncreasedRiskCataracts1.14
IncreasedOS1.02
IncreasedBrCaDFS1.21


Fold #4 **************************************************************************************************
Thing
IncreasedBrCaDFS1.05
IncreasedBrCaDFS1.7
DecreasedBrCaDFS0.8
IncreasedRiskEndometrialCancer2.53
ProtoERNegLNPosStage1BrCa
DecreasedEndoCaDSS0.66
PlasmaCholesterolInst
DecreasedCholesterol0.88
RiskCataracts0.14
ProtoERPosLNNegStage2BrCa
IncreasedRiskVenousThrombosis3.4
DecreasedRiskBrCa0.01
DecreasedRiskBrCa0.6
PersistentSideEffectsInst
ProtoERNegLNNegStage2BrCa
ProtoLNNeg
IncreasedBrCaDFS1.5
ProtoClonidine
IncreasedRiskGastricCa3.0
IncreasedOS1.2
ProtoEndoAbnormality
RiskRetinopathy0.12
ProtoEndoCa
DecreasedRiskFatalMI0.37
IncreasedLumbarBMD1.008
ProtoERPosLNNegStage1BrCa
IncreasedRiskPersistentSideEffects2.3
IncreasedRiskEndometrialCancer7.5
RadialBMDLevel
DecreasedPlasmaPlateletCount0.92
ProtoPoorPrognosis
ProtoPostmenopausal
ProtoStage1
TamC40mg
ProtoPFTChemoTam
LumbarBMDLevel
DecreasedRiskHotFlushes0.8
IncreasedBrCaDFSREF
DecreasedRiskCardiacDisease0.68
IncreasedBrCaDFS1.2
ProtoERPos
ProtoRetinopathy
DecreasedLumbarBMD0.993
IncreasedBrCaDFS1.3
IncreasedRiskCRC1.9
IncreasedBrCaDFS1.1
TamA20mg
IncreasedRiskRetinopathy1.52
NoChangeRiskEndometrialAbnormality1
TamD2Yr
ProtoERNegLNPosStage2BrCa
RiskOvarianCyst0.11
ProtoNoChangeOS
IncreasedLumbarBMD1.012
IncreasedOS1.03
DecreasedBrCaDFS0.5
ProtoPremenopausal
DecreasedRiskBrCa0.55
MsJones
ProtoERNeg
RiskOvarianCyst0.06
ProtoACT
DecreasedRadialBMD_NOS
IncreasedCardiacDSS1.52
IncreasedRiskGastricCa3.2
ProtoGastricCa
ProtoColorectalCa
ProtoStroke
PlasmaPlatelet
ECMFTypeInstance
ProtoVenousThrombosis
IncreasedRiskEndometrialCancer6.4
ProtoPAFTChemoTam
DecreasedLumbarBMD0.986
IncreasedBrCaDFS1.x
IncreasedOS1.1
RiskEndometrialCa0.005
NoChangeRadialBMD1.0
NoChangeBrCaDFS1
DecreasedPlasmaFibrinogenLevel0.85
ProtoLNPos
ProtoNonFatalMI
ProtoERPosLNPosStage1BrCa
IncreasedLumbarBMD1.006
Tam30mg
RiskEndometrialAbnormality3.9
TamFgt5Yr
ProtoFatalMI
IncreasedRiskEndometrialCancer2.3
ProtoHotFlushes
ProtoPRNeg
ProtoLateCMFTChemTam
ProtoPRPos
DecreasedEndoCaDFS0.66
ProtoERNegLNNegStage1BrCa
IncreasedRiskEndometrialCancer6.0
TamE5Yr
IncreasedRiskCataracts1.14
IncreasedOS1.02
IncreasedBrCaDFS1.21


Fold #5 **************************************************************************************************
Thing
IncreasedBrCaDFS1.05
IncreasedBrCaDFS1.7
DecreasedBrCaDFS0.8
IncreasedRiskEndometrialCancer2.53
ProtoERNegLNPosStage1BrCa
DecreasedEndoCaDSS0.66
PlasmaCholesterolInst
DecreasedCholesterol0.88
RiskCataracts0.14
ProtoERPosLNNegStage2BrCa
IncreasedRiskVenousThrombosis3.4
DecreasedRiskBrCa0.01
DecreasedRiskBrCa0.6
PersistentSideEffectsInst
ProtoERNegLNNegStage2BrCa
ProtoLNNeg
IncreasedBrCaDFS1.5
ProtoClonidine
IncreasedRiskGastricCa3.0
IncreasedOS1.2
ProtoEndoAbnormality
RiskRetinopathy0.12
ProtoEndoCa
DecreasedRiskFatalMI0.37
IncreasedLumbarBMD1.008
ProtoERPosLNNegStage1BrCa
IncreasedRiskPersistentSideEffects2.3
IncreasedRiskEndometrialCancer7.5
RadialBMDLevel
DecreasedPlasmaPlateletCount0.92
ProtoPoorPrognosis
ProtoPostmenopausal
ProtoStage1
TamC40mg
ProtoPFTChemoTam
LumbarBMDLevel
DecreasedRiskHotFlushes0.8
IncreasedBrCaDFSREF
DecreasedRiskCardiacDisease0.68
IncreasedBrCaDFS1.2
ProtoERPos
ProtoRetinopathy
DecreasedLumbarBMD0.993
IncreasedBrCaDFS1.3
IncreasedRiskCRC1.9
IncreasedBrCaDFS1.1
TamA20mg
ProtoMFTChemoTam
IncreasedRiskEndometrialCancer4.1
ProtoStage2
ProtoEarlyCMFTChemoTam
ProtoEndometrialAbnormality
DecreasedLDL0.88
IncreasedRiskSideEffects23
PlasmaFibrinogen
PlasmaLDL
ProtoStage4
ProtoStage3
ProtoERPosLNPosStage2BrCa
ProtoERNeg
RiskOvarianCyst0.06
ProtoACT
DecreasedRadialBMD_NOS
IncreasedCardiacDSS1.52
IncreasedRiskGastricCa3.2
ProtoGastricCa
ProtoColorectalCa
ProtoStroke
PlasmaPlatelet
ECMFTypeInstance
ProtoVenousThrombosis
IncreasedRiskEndometrialCancer6.4
ProtoPAFTChemoTam
DecreasedLumbarBMD0.986
IncreasedBrCaDFS1.x
IncreasedOS1.1
RiskEndometrialCa0.005
NoChangeRadialBMD1.0
NoChangeBrCaDFS1
DecreasedPlasmaFibrinogenLevel0.85
ProtoLNPos
ProtoNonFatalMI
ProtoERPosLNPosStage1BrCa
IncreasedLumbarBMD1.006
Tam30mg
RiskEndometrialAbnormality3.9
TamFgt5Yr
ProtoFatalMI
IncreasedRiskEndometrialCancer2.3
ProtoHotFlushes
ProtoPRNeg
ProtoLateCMFTChemTam
ProtoPRPos
DecreasedEndoCaDFS0.66
ProtoERNegLNNegStage1BrCa
IncreasedRiskEndometrialCancer6.0
TamE5Yr
IncreasedRiskCataracts1.14
IncreasedOS1.02
IncreasedBrCaDFS1.21


Fold #6 **************************************************************************************************
Thing
IncreasedBrCaDFS1.05
IncreasedBrCaDFS1.7
DecreasedBrCaDFS0.8
IncreasedRiskEndometrialCancer2.53
ProtoERNegLNPosStage1BrCa
DecreasedEndoCaDSS0.66
PlasmaCholesterolInst
DecreasedCholesterol0.88
RiskCataracts0.14
ProtoERPosLNNegStage2BrCa
IncreasedRiskVenousThrombosis3.4
DecreasedRiskBrCa0.01
DecreasedRiskBrCa0.6
PersistentSideEffectsInst
ProtoERNegLNNegStage2BrCa
ProtoLNNeg
IncreasedBrCaDFS1.5
ProtoClonidine
IncreasedRiskGastricCa3.0
IncreasedOS1.2
ProtoEndoAbnormality
RiskRetinopathy0.12
ProtoEndoCa
DecreasedRiskFatalMI0.37
IncreasedLumbarBMD1.008
ProtoERPosLNNegStage1BrCa
IncreasedRiskPersistentSideEffects2.3
IncreasedRiskEndometrialCancer7.5
RadialBMDLevel
DecreasedPlasmaPlateletCount0.92
ProtoPoorPrognosis
ProtoPostmenopausal
ProtoStage1
TamC40mg
ProtoPFTChemoTam
LumbarBMDLevel
DecreasedRiskHotFlushes0.8
IncreasedBrCaDFSREF
DecreasedRiskCardiacDisease0.68
IncreasedBrCaDFS1.2
ProtoERPos
ProtoRetinopathy
DecreasedLumbarBMD0.993
IncreasedBrCaDFS1.3
IncreasedRiskCRC1.9
IncreasedBrCaDFS1.1
TamA20mg
ProtoMFTChemoTam
IncreasedRiskEndometrialCancer4.1
ProtoStage2
ProtoEarlyCMFTChemoTam
ProtoEndometrialAbnormality
DecreasedLDL0.88
IncreasedRiskSideEffects23
PlasmaFibrinogen
PlasmaLDL
ProtoStage4
ProtoStage3
ProtoERPosLNPosStage2BrCa
IncreasedRiskRetinopathy1.52
NoChangeRiskEndometrialAbnormality1
TamD2Yr
ProtoERNegLNPosStage2BrCa
RiskOvarianCyst0.11
ProtoNoChangeOS
IncreasedLumbarBMD1.012
IncreasedOS1.03
DecreasedBrCaDFS0.5
ProtoPremenopausal
DecreasedRiskBrCa0.55
MsJones
IncreasedRiskEndometrialCancer6.4
ProtoPAFTChemoTam
DecreasedLumbarBMD0.986
IncreasedBrCaDFS1.x
IncreasedOS1.1
RiskEndometrialCa0.005
NoChangeRadialBMD1.0
NoChangeBrCaDFS1
DecreasedPlasmaFibrinogenLevel0.85
ProtoLNPos
ProtoNonFatalMI
ProtoERPosLNPosStage1BrCa
IncreasedLumbarBMD1.006
Tam30mg
RiskEndometrialAbnormality3.9
TamFgt5Yr
ProtoFatalMI
IncreasedRiskEndometrialCancer2.3
ProtoHotFlushes
ProtoPRNeg
ProtoLateCMFTChemTam
ProtoPRPos
DecreasedEndoCaDFS0.66
ProtoERNegLNNegStage1BrCa
IncreasedRiskEndometrialCancer6.0
TamE5Yr
IncreasedRiskCataracts1.14
IncreasedOS1.02
IncreasedBrCaDFS1.21


Fold #7 **************************************************************************************************
Thing
IncreasedBrCaDFS1.05
IncreasedBrCaDFS1.7
DecreasedBrCaDFS0.8
IncreasedRiskEndometrialCancer2.53
ProtoERNegLNPosStage1BrCa
DecreasedEndoCaDSS0.66
PlasmaCholesterolInst
DecreasedCholesterol0.88
RiskCataracts0.14
ProtoERPosLNNegStage2BrCa
IncreasedRiskVenousThrombosis3.4
DecreasedRiskBrCa0.01
DecreasedRiskBrCa0.6
PersistentSideEffectsInst
ProtoERNegLNNegStage2BrCa
ProtoLNNeg
IncreasedBrCaDFS1.5
ProtoClonidine
IncreasedRiskGastricCa3.0
IncreasedOS1.2
ProtoEndoAbnormality
RiskRetinopathy0.12
ProtoEndoCa
DecreasedRiskFatalMI0.37
IncreasedLumbarBMD1.008
ProtoERPosLNNegStage1BrCa
IncreasedRiskPersistentSideEffects2.3
IncreasedRiskEndometrialCancer7.5
RadialBMDLevel
DecreasedPlasmaPlateletCount0.92
ProtoPoorPrognosis
ProtoPostmenopausal
ProtoStage1
TamC40mg
ProtoPFTChemoTam
LumbarBMDLevel
DecreasedRiskHotFlushes0.8
IncreasedBrCaDFSREF
DecreasedRiskCardiacDisease0.68
IncreasedBrCaDFS1.2
ProtoERPos
ProtoRetinopathy
DecreasedLumbarBMD0.993
IncreasedBrCaDFS1.3
IncreasedRiskCRC1.9
IncreasedBrCaDFS1.1
TamA20mg
ProtoMFTChemoTam
IncreasedRiskEndometrialCancer4.1
ProtoStage2
ProtoEarlyCMFTChemoTam
ProtoEndometrialAbnormality
DecreasedLDL0.88
IncreasedRiskSideEffects23
PlasmaFibrinogen
PlasmaLDL
ProtoStage4
ProtoStage3
ProtoERPosLNPosStage2BrCa
IncreasedRiskRetinopathy1.52
NoChangeRiskEndometrialAbnormality1
TamD2Yr
ProtoERNegLNPosStage2BrCa
RiskOvarianCyst0.11
ProtoNoChangeOS
IncreasedLumbarBMD1.012
IncreasedOS1.03
DecreasedBrCaDFS0.5
ProtoPremenopausal
DecreasedRiskBrCa0.55
MsJones
ProtoERNeg
RiskOvarianCyst0.06
ProtoACT
DecreasedRadialBMD_NOS
IncreasedCardiacDSS1.52
IncreasedRiskGastricCa3.2
ProtoGastricCa
ProtoColorectalCa
ProtoStroke
PlasmaPlatelet
ECMFTypeInstance
ProtoVenousThrombosis
IncreasedLumbarBMD1.006
Tam30mg
RiskEndometrialAbnormality3.9
TamFgt5Yr
ProtoFatalMI
IncreasedRiskEndometrialCancer2.3
ProtoHotFlushes
ProtoPRNeg
ProtoLateCMFTChemTam
ProtoPRPos
DecreasedEndoCaDFS0.66
ProtoERNegLNNegStage1BrCa
IncreasedRiskEndometrialCancer6.0
TamE5Yr
IncreasedRiskCataracts1.14
IncreasedOS1.02
IncreasedBrCaDFS1.21


Fold #8 **************************************************************************************************
Thing
IncreasedBrCaDFS1.05
IncreasedBrCaDFS1.7
DecreasedBrCaDFS0.8
IncreasedRiskEndometrialCancer2.53
ProtoERNegLNPosStage1BrCa
DecreasedEndoCaDSS0.66
PlasmaCholesterolInst
DecreasedCholesterol0.88
RiskCataracts0.14
ProtoERPosLNNegStage2BrCa
IncreasedRiskVenousThrombosis3.4
DecreasedRiskBrCa0.01
DecreasedRiskBrCa0.6
PersistentSideEffectsInst
ProtoERNegLNNegStage2BrCa
ProtoLNNeg
IncreasedBrCaDFS1.5
ProtoClonidine
IncreasedRiskGastricCa3.0
IncreasedOS1.2
ProtoEndoAbnormality
RiskRetinopathy0.12
ProtoEndoCa
DecreasedRiskFatalMI0.37
IncreasedLumbarBMD1.008
ProtoERPosLNNegStage1BrCa
IncreasedRiskPersistentSideEffects2.3
IncreasedRiskEndometrialCancer7.5
RadialBMDLevel
DecreasedPlasmaPlateletCount0.92
ProtoPoorPrognosis
ProtoPostmenopausal
ProtoStage1
TamC40mg
ProtoPFTChemoTam
LumbarBMDLevel
DecreasedRiskHotFlushes0.8
IncreasedBrCaDFSREF
DecreasedRiskCardiacDisease0.68
IncreasedBrCaDFS1.2
ProtoERPos
ProtoRetinopathy
DecreasedLumbarBMD0.993
IncreasedBrCaDFS1.3
IncreasedRiskCRC1.9
IncreasedBrCaDFS1.1
TamA20mg
ProtoMFTChemoTam
IncreasedRiskEndometrialCancer4.1
ProtoStage2
ProtoEarlyCMFTChemoTam
ProtoEndometrialAbnormality
DecreasedLDL0.88
IncreasedRiskSideEffects23
PlasmaFibrinogen
PlasmaLDL
ProtoStage4
ProtoStage3
ProtoERPosLNPosStage2BrCa
IncreasedRiskRetinopathy1.52
NoChangeRiskEndometrialAbnormality1
TamD2Yr
ProtoERNegLNPosStage2BrCa
RiskOvarianCyst0.11
ProtoNoChangeOS
IncreasedLumbarBMD1.012
IncreasedOS1.03
DecreasedBrCaDFS0.5
ProtoPremenopausal
DecreasedRiskBrCa0.55
MsJones
ProtoERNeg
RiskOvarianCyst0.06
ProtoACT
DecreasedRadialBMD_NOS
IncreasedCardiacDSS1.52
IncreasedRiskGastricCa3.2
ProtoGastricCa
ProtoColorectalCa
ProtoStroke
PlasmaPlatelet
ECMFTypeInstance
ProtoVenousThrombosis
IncreasedRiskEndometrialCancer6.4
ProtoPAFTChemoTam
DecreasedLumbarBMD0.986
IncreasedBrCaDFS1.x
IncreasedOS1.1
RiskEndometrialCa0.005
NoChangeRadialBMD1.0
NoChangeBrCaDFS1
DecreasedPlasmaFibrinogenLevel0.85
ProtoLNPos
ProtoNonFatalMI
ProtoERPosLNPosStage1BrCa
IncreasedRiskEndometrialCancer6.0
TamE5Yr
IncreasedRiskCataracts1.14
IncreasedOS1.02
IncreasedBrCaDFS1.21


Fold #9 **************************************************************************************************
Thing
IncreasedBrCaDFS1.05
IncreasedBrCaDFS1.7
DecreasedBrCaDFS0.8
IncreasedRiskEndometrialCancer2.53
ProtoERNegLNPosStage1BrCa
DecreasedEndoCaDSS0.66
PlasmaCholesterolInst
DecreasedCholesterol0.88
RiskCataracts0.14
ProtoERPosLNNegStage2BrCa
IncreasedRiskVenousThrombosis3.4
DecreasedRiskBrCa0.01
DecreasedRiskBrCa0.6
PersistentSideEffectsInst
ProtoERNegLNNegStage2BrCa
ProtoLNNeg
IncreasedBrCaDFS1.5
ProtoClonidine
IncreasedRiskGastricCa3.0
IncreasedOS1.2
ProtoEndoAbnormality
RiskRetinopathy0.12
ProtoEndoCa
DecreasedRiskFatalMI0.37
IncreasedLumbarBMD1.008
ProtoERPosLNNegStage1BrCa
IncreasedRiskPersistentSideEffects2.3
IncreasedRiskEndometrialCancer7.5
RadialBMDLevel
DecreasedPlasmaPlateletCount0.92
ProtoPoorPrognosis
ProtoPostmenopausal
ProtoStage1
TamC40mg
ProtoPFTChemoTam
LumbarBMDLevel
DecreasedRiskHotFlushes0.8
IncreasedBrCaDFSREF
DecreasedRiskCardiacDisease0.68
IncreasedBrCaDFS1.2
ProtoERPos
ProtoRetinopathy
DecreasedLumbarBMD0.993
IncreasedBrCaDFS1.3
IncreasedRiskCRC1.9
IncreasedBrCaDFS1.1
TamA20mg
ProtoMFTChemoTam
IncreasedRiskEndometrialCancer4.1
ProtoStage2
ProtoEarlyCMFTChemoTam
ProtoEndometrialAbnormality
DecreasedLDL0.88
IncreasedRiskSideEffects23
PlasmaFibrinogen
PlasmaLDL
ProtoStage4
ProtoStage3
ProtoERPosLNPosStage2BrCa
IncreasedRiskRetinopathy1.52
NoChangeRiskEndometrialAbnormality1
TamD2Yr
ProtoERNegLNPosStage2BrCa
RiskOvarianCyst0.11
ProtoNoChangeOS
IncreasedLumbarBMD1.012
IncreasedOS1.03
DecreasedBrCaDFS0.5
ProtoPremenopausal
DecreasedRiskBrCa0.55
MsJones
ProtoERNeg
RiskOvarianCyst0.06
ProtoACT
DecreasedRadialBMD_NOS
IncreasedCardiacDSS1.52
IncreasedRiskGastricCa3.2
ProtoGastricCa
ProtoColorectalCa
ProtoStroke
PlasmaPlatelet
ECMFTypeInstance
ProtoVenousThrombosis
IncreasedRiskEndometrialCancer6.4
ProtoPAFTChemoTam
DecreasedLumbarBMD0.986
IncreasedBrCaDFS1.x
IncreasedOS1.1
RiskEndometrialCa0.005
NoChangeRadialBMD1.0
NoChangeBrCaDFS1
DecreasedPlasmaFibrinogenLevel0.85
ProtoLNPos
ProtoNonFatalMI
ProtoERPosLNPosStage1BrCa
IncreasedLumbarBMD1.006
Tam30mg
RiskEndometrialAbnormality3.9
TamFgt5Yr
ProtoFatalMI
IncreasedRiskEndometrialCancer2.3
ProtoHotFlushes
ProtoPRNeg
ProtoLateCMFTChemTam
ProtoPRPos
DecreasedEndoCaDFS0.66
ProtoERNegLNNegStage1BrCa
